Tuesday, September 22, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorygray marketmenopauseresearch peptidestelehealth

Women self-dose gray-market research peptides for menopause symptoms, New York Post reports

An NYU Langone endocrinologist says undertreated menopausal symptoms are pushing patients toward online sellers and self-devised protocols with no medical oversight.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 22 06:59 ETSource: New York Post

The wire

  1. 01The New York Post reports a growing number of women are buying peptides labeled research use only online for hot flashes, fatigue, low libido, joint pain and memory problems, often building their own protocols.
  2. 02Clinicians are fielding these questions directly; NYU Langone's Rachel Pessah-Pollack says undertreated menopause symptoms are driving patients to alternative pathways outside clinical care.
  3. 03The account is anecdotal, with users including a 56-year-old who researched via internet searches and ChatGPT; no clinical evidence of benefit for menopause is cited.

From the source

Exclusive | Women are using experimental peptides to treat menopause symptoms

Stephanie Corn was shopping for shoes in Houston when a terrifying realization stopped her cold: She had no idea where she was.

Read at nypost.com